Delivery Order SPE2DR25D2101-SPE2DR26F46RX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order, valued at $6,092.16, is set to be completed by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for AVEED 750 mg/3 mL vials with a ceiling value of $2,030.72. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition for the pharmaceutical supply. The contract is set to be completed by December 31, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $30,460.80 for AVEED 750 mg/3 mL vials on November 17, 2025, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $5,780.82 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on September 23, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contractor's place of performance is located in Conshohocken, Pennsylvania, the company's headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The order carries a ceiling value of $34,684.92 and is structured as a firm fixed-price delivery order with an ultimate completion date of June 23, 2025. This is a non-set-aside contract awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,452.05 by the Defense Logistics Agency on September 15, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract utilizes firm fixed price pricing and is scheduled for completion by October 6, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $34,684.92 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 5, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $3,853.88 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 ml vials on September 10, 2025, with an ultimate completion date of October 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,300.50 firm fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on July 26, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46RXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of AVEED 750 mg/3 mL vials with a ceiling value of $4,061.44. This firm fixed-price delivery order is scheduled for completion by January 13, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime contract valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a broad portfolio of medications and medical supplies to support military and federal healthcare systems. The company's federal contract portfolio includes diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies, positioning it as a critical vendor for the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/18/25 |